- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
- 10-Q Quarterly report
- 4.2 Common Stock Purchase Warrant, Dated April 13, 2009
- 4.3 Common Stock Purchase Warrant, Dated May 11, 2009
- 15 Letter Regarding Unaudited Interim Financial Information
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32 Section 906 CEO and CFO Certification
Exhibit No. 15
August 6, 2009
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated August 6, 2009 on our review of interim financial information of Cell Therapeutics, Inc. for the six month period ended June 30, 2009 included in the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2009 is incorporated by reference in the Registration Statements of Cell Therapeutics, Inc. on Forms S-3 (File Nos. 333-130411, 333-131533, 333-130004, 333-36038, 333-41300, 333-67906, 333-36603, 333-38431, 333-108926, 333-112681, 333-138170, 333-134126, 333-14352, 333-149980, 333-149981, 333-149982, 333-152170, 333-152171, 333-152172, 333-160969, 333-158272, 333-157376, and 333-153358) and on Form S-8 (File No. 333-65200, 333-58957, 333-35919, 333-97015, 333-106568, 333-106571, 333-112791, 333-118016, 333-146624, 333-152168 and 333-158260).
Yours very truly, |
/s/ Stonefield Josephson, Inc. |